Fusion Scans
Back

ASND

NASDAQ
Ascendis Pharma A/S · Healthcare · Biotechnology
Loading quote…

Highlights

Market Cap
$14.86B
PE Ratio
EV to Ebitda
Earnings Yield
-1.83%
Revenue (TTM)
$823.1M
Net Income (TTM)
$-254.0M
Revenue (Annual YoY Growth)
106.62%
Revenue (Quarterly YoY Growth)
55.28%
Profit Margin
-30.85%
Return on Equity
Debt to Equity Ratio
-5.3543
Dividend Yield
0.00%

All fundamentals

Core7 fields
Market Cap$14.86B
Revenue TTM$823.1M
Shares Outstanding61.8M
Float55874661
Volume120346
Relative Strength70.8
GARP4094
Growth Estimates14 fields
Revenue Growth (Annual)106.62%
Revenue Growth (Quarterly YoY)55.28%
Operating Revenue Growth (Annual)0.922698
Operating Revenue Growth (Quarterly YoY)2.497565
3-Year Revenue Growth147.23%
5-Year Revenue Growth152.45%
EPS Growth (Annual)39.89%
EPS Growth (Quarterly YoY)7.19%
3-Year EPS Growth Rate0.00%
5-Year EPS Growth Rate0.00%
EBITDA Growth (Annual)52.61%
EBITDA Growth (Quarterly YoY)230.63%
CFO Growth (Annual)118.37%
CFO Growth (Quarterly YoY)199.30%
Operations28 fields
Revenue TTM$823.1M
Gross Margin TTM84.81%
Gross Margin (Quarterly)88.91%
R&D % of Revenue TTM40.37%
R&D Expenses TTM$332.3M
Operating Margin TTM-17.66%
Operating Margin (Quarterly)4.00%
Operating Expenses TTM$843.4M
Profit Margin TTM-30.85%
Profit Margin (Quarterly)-13.56%
Net Income TTM$-254.0M
EPS TTM-4.1973
EPS (Quarterly)-0.6364
EBIT Margin TTM-17.66%
EBIT Margin (Quarterly)4.00%
EBITDA Margin TTM-15.23%
EBITDA Margin (Quarterly)5.95%
EBITDA TTM$-125.3M
CFO % of Revenue TTM7.48%
CFO % of Revenue (Quarterly)29.67%
CFO TTM$62.7M
Cash Margin7.47%
Capex % of Revenue TTM1.20%
Capital Expenditures$9.9M
FCF % of Revenue TTM6.31%
FCF % of Revenue (Quarterly)28.31%
FCF TTM$52.8M
Fundamental Score3
Efficiency5 fields
ROA-19.44%
ROIC-33.58%
CROCI6.98%
Stock Comp % (Quarterly)11.94%
Stock Comp % TTM16.13%
Valuation14 fields
P/E Forward69.5821
P/S Forward8.8463
P/CFO221.9269
P/FCF263.3929
EV/EBITDA Forward26.3964
EV/Revenues (TTM)17.5812
EV/Revenues Forward9.0338
EV/CFO213.5786
EV/FCF (TTM)273.9754
Price to Tangible Book7.1441
Earnings Yield-1.83%
FCF Yield0.38%
Dividend Yield0.00%
Value Score1
Relative to Industry3 fields
Relative Gross Margin (Quarterly)1.1391
Relative P/S2.7553
Relative Dividend Yield0
Liquidity15 fields
Cash Per Share11.7873
Current Ratio1.037
Cash & ST Assets$723.5M
Total Debt$956.8M
Goodwill & Intangibles$4.4M
Total Assets$1.53B
Total Liabilities$1.72B
Shareholders Equity$-191.2M
Debt to Equity-5.3543
Debt to Assets66.93%
Interest Expense$234.9M
Times Interest Earned-0.6187
CFO to Debt (TTM)0.0665
Debt to EBITDA (TTM)-7.519
Goodwill % of Assets0.28%
Yields4 fields
Dividend Yield0.00%
Earnings Yield-1.83%
Buyback Yield-0.57%
Shareholder Yield-0.84%
Options Flow8 fields
Call Volume63
Put Volume29
Put/Call Ratio0.4603174603174603
Call $ Volume106091
Put $ Volume134769
Put/Call $ Ratio1.2703151068422391
Call OI7431
Put OI3673

News AI summary

Past 90 days of news, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Press release AI summary

Past 90 days of press releases, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Income statement AI analysis

Recent quarterly income statements with margin trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Balance sheet AI analysis

Recent quarterly balance sheets with leverage trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Cash flow AI analysis

Recent quarterly cash flow statements with FCF trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.